Exact sciences maybe feeling a little ripped off.
What a fantastic well written RNS. Great work to Gabriele and the team.
I hear p0rnhub are giving out free premium subscriptions, knock yourself out, that should calm the nerves.
Pun not intended or maybe it was :D
None the less, cannot wait to hear what our CEO has in store for us with our new little demerge venture and who is willing to buy it out.
No doubt it'll cast a big shadow over any other investments i've made over the years.
@safy,
it was a total d!ck move by the CEO. Someone mentioned that it's a game of nerves on the ODX board and I totally disagree.
Some people lose logic because they are not physically receiving a tangible asset at the end of their purchase. Most people would change their approach if they did.
Buying something at 50% higher on the day with no official comms is ludicrous, yet alone 80% / 90%.
I'm not going to lie, my heart kept telling me slice here and buy back in there but my head kept telling me no.
Removing the emotion has to be the hardest part of investing.
The fear of missing out hits most and they get stung in the process.
Shame, genuinely feel for those that have been spiked though.
I fall under the category that sold a couple of weeks ago but the deramping is OTT.
The company is doing great work alongside educational institutes with the likes of Oxford Uni and being part of the consortiums. I have no doubt that this will break £1 in the near future.
The CEO needs to get his comms straight. Issuing a speeding ticket like that at 16:00 is wrong. It should have been immediately issued after the interview when it was up 50%. An RNS should have been issued prior to the news interview.
You have to feel for them though. Unwitting investors, jumping onto the band waggon based on the sky news interview to be shafted by the same man who was providing the interview. That RNS should have been immediately issued. I'm glad I dumped it all at 60 & 50p and moved it into here a couple weeks ago.
NGL, it did make me feel a bit sick seeing it constantly rise from 50p to 90p. Hey ho, come on TILS you beauty!
I genuinely feel for those that have been spiked. I've been watching the climb all day second guessing where it was going to go and whether to sell another share to get back in my nerves made me hold off with the intention if it drops back below 70p I would get back in.
I'm no longer invested in here. Sold up at 60p and 47p a couple of weeks ago. When Roche announced their antibody test and that the UK Govt would be using them it was enough for me to have enjoyed a few pounds profit and call it a day.
To those that have been spiked, i've been stung many times before. You're currently sat on a paper loss. I have big hopes for this company in the current climate that we are in and I do expect ODX to be valued at over £1 in the near future. Just hang in there all is not lost. It's only a loss until you sell.
If you do want to cut loose and try invest else where there are many other companies that have potential to rise. I am invested in TILS and anticipate big thing there soon.
I wish you all the best. Spend time with your families. Money comes and goes.
They write that in most of their RNS. Not sure why. I’ve always had an underlying suspicion that either severnickle or Norilsk would be the buyers. Time will tell.
Have to admit this is my most stable stock in my portfolio LOL. Hasn’t budged a penny since Rona came out haha.
Jesting of course
Eid Mubarak to my fellow Tiziana-ians whether you do or do not celebrate. Hope you and your families have a blessed day.
Demerge a part of the company to run independently under the same parent company. The RNS initially reads like you suggested from the title but as you read the detail it possibly suggests that they are looking to sell it off.
It’s like casp demerging the shallows from the main casp portfolio. 1. It’ll make it easier to run seperately 2. If Exxon comes knocking on the door you can present the portfolio much easier of the specific value opposed to the entire company.
It reeks buy out, if you have a ground breaking discovery but had no intention to commercialise it you keep it in house secured under lock and key.
This is being separated to run independently as a separate entity. It’ll allow the rights to remain under the new company opposed to having to transfer ownership at the time of sale.
It is essentially creating the profile for the company saying this is what is up for sale and this is what we are keeping
Focusing on this paragraph
Allow Shareholders to benefit from both Tiziana's rapidly developing drug portfolio and the standalone value of StemPrintER as it progresses through its own development milestones and the path to commercialization and allow shareholders to receive the maximum potential value from StemPrintER as a standalone entity.
To me this suggests that they have been approached for potential buyout and have been legally advised to create a new arm under the TILS umbrella. It will enable a sale of the arm much easier opposed to splitting assets at the time of sale.
Should be a £1 + day